GOETTLER MICHAEL 4

What Happened
Michael Goettler, a director of Bausch Health Companies Inc. (BHC), was granted 45,871 restricted share units (RSUs) on 2026-05-22. The grant was recorded at $0.00 per share for acquisition reporting purposes, with a stated grant-date value of $250,000. The RSUs vest on the day immediately before the issuer’s next Annual Meeting of Shareholders and will be settled in common shares when vested. This was an award/compensation grant (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-22 (reported on Form 4 filed 2026-05-26).
• Reported acquisition price: $0.00 (award/grant).
• Shares awarded: 45,871 RSUs; grant-date value: $250,000.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote: RSUs granted to non-employee directors on the third business day after their election; they vest the day before the next Annual Meeting and will be settled in common shares.
• Filing timeliness: Form 4 filed 2026-05-26; given the May 25 federal holiday, this appears to meet the two-business-day filing requirement.

Context
RSU awards to non-employee directors are routine compensation and do not reflect an open-market buy or sell. The award will only increase Goettler’s share count (and potential voting power) once the RSUs vest and are settled into common shares. No tax-withholding or sale-on-vesting details were reported in the provided filing.